Our validated multiplex Luminex assay offers significantly enhanced sensitivity (10-100 pg/mL) for quantifying 15 crucial pro- and anti-inflammatory cytokines in NHP serum and plasma, far exceeding the limitations of traditional methods (100-300 pg/mL). Developed in strict adherence to FDA M10 guidelines, this robust assay delivers precise and accurate data, essential for comprehensive preclinical drug evaluation.
This poster highlights:
- Enhanced sensitivity (10-100 pg/mL).
- Comprehensive 15-cytokine profiling.
- Efficient use of small volume of NHP samples.
- Robust, reliable validated data.
- Streamlined data analysis using validated sample tracking and analysis tools.
By enabling the detection of lower cytokine levels, our assay provides a deeper understanding of complex immune responses, optimizing preclinical trials and facilitating smoother transitions to human studies.
Explore how our advanced Luminex assay can elevate your preclinical research. Click here to view the full poster.
